• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中mRNA翻译与能量代谢的失调。

Dysregulation of mRNA translation and energy metabolism in cancer.

作者信息

Leibovitch Matthew, Topisirovic Ivan

机构信息

Lady Davis Institute, SMBD JGH, McGill University, Montréal, QC, H3T 1E2, Canada.

Gerald Bronfman Department of Oncology, Montréal, QC, H3A 1A3, Canada; Department of Biochemistry, Montréal, QC, H3A 1A3, Canada; Department of Experimental Medicine McGill University, Montréal, QC, H3A 1A3, Canada; Lady Davis Institute, SMBD JGH, McGill University, Montréal, QC, H3T 1E2, Canada.

出版信息

Adv Biol Regul. 2018 Jan;67:30-39. doi: 10.1016/j.jbior.2017.11.001. Epub 2017 Nov 2.

DOI:10.1016/j.jbior.2017.11.001
PMID:29150352
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5993950/
Abstract

Dysregulated mRNA translation and aberrant energy metabolism are frequent in cancer. Considering that mRNA translation is an energy demanding process, cancer cells must produce sufficient ATP to meet energy demand of hyperactive translational machinery. In recent years, the mammalian/mechanistic target of rapamycin (mTOR) emerged as a central regulatory node which coordinates energy consumption by the translation apparatus and ATP production in mitochondria. Aberrant mTOR signaling underpins the vast majority of cancers whereby increased mTOR activity is thought to be a major determinant of both malignant translatomes and metabolomes. Nonetheless, the role of mTOR and other related signaling nodes (e.g. AMPK) in orchestrating protein synthesis and cancer energetics is only recently being unraveled. In this review, we discuss recent findings that provide insights into the molecular underpinnings of coordination of translational and metabolic programs of cancer cells, and potential strategies to translate these findings into clinical treatments.

摘要

mRNA翻译失调和能量代谢异常在癌症中很常见。鉴于mRNA翻译是一个耗能过程,癌细胞必须产生足够的ATP以满足过度活跃的翻译机制的能量需求。近年来,哺乳动物/雷帕霉素机制性靶标(mTOR)成为一个核心调节节点,它协调翻译装置的能量消耗和线粒体中的ATP生成。异常的mTOR信号传导是绝大多数癌症的基础,其中mTOR活性增加被认为是恶性翻译组和代谢组的主要决定因素。尽管如此,mTOR和其他相关信号节点(如AMPK)在协调蛋白质合成和癌症能量代谢方面的作用直到最近才被揭示。在这篇综述中,我们讨论了最近的研究发现,这些发现为癌细胞翻译和代谢程序协调的分子基础提供了见解,以及将这些发现转化为临床治疗的潜在策略。

相似文献

1
Dysregulation of mRNA translation and energy metabolism in cancer.癌症中mRNA翻译与能量代谢的失调。
Adv Biol Regul. 2018 Jan;67:30-39. doi: 10.1016/j.jbior.2017.11.001. Epub 2017 Nov 2.
2
Translational control by oncogenic signaling pathways.致癌信号通路的翻译调控
Biochim Biophys Acta. 2015 Jul;1849(7):753-65. doi: 10.1016/j.bbagrm.2014.11.006. Epub 2014 Dec 2.
3
Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia.致癌激酶以及肿瘤发生中蛋白质合成机器和能量代谢的改变。
J Mol Endocrinol. 2019 Feb 1;62(2):R83-R103. doi: 10.1530/JME-18-0058.
4
Stress-mediated translational control in cancer cells.癌细胞中应激介导的翻译控制。
Biochim Biophys Acta. 2015 Jul;1849(7):845-60. doi: 10.1016/j.bbagrm.2014.11.002. Epub 2014 Nov 10.
5
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.靶向翻译机制改善白血病治疗:PI3K/PTEN/Akt/mTOR 通路的作用。
Leukemia. 2011 Jul;25(7):1064-79. doi: 10.1038/leu.2011.46. Epub 2011 Mar 25.
6
mTOR coordinates protein synthesis, mitochondrial activity and proliferation.mTOR协调蛋白质合成、线粒体活性和增殖。
Cell Cycle. 2015;14(4):473-80. doi: 10.4161/15384101.2014.991572.
7
mTORC1 controls mitochondrial activity and biogenesis through 4E-BP-dependent translational regulation.mTORC1 通过 4E-BP 依赖性翻译调控控制线粒体活性和生物发生。
Cell Metab. 2013 Nov 5;18(5):698-711. doi: 10.1016/j.cmet.2013.10.001.
8
Signaling Pathways Involved in the Regulation of mRNA Translation.参与调控 mRNA 翻译的信号通路。
Mol Cell Biol. 2018 May 29;38(12). doi: 10.1128/MCB.00070-18. Print 2018 Jun 15.
9
Cap-independent translation ensures mTOR expression and function upon protein synthesis inhibition.不依赖帽依赖性的翻译在蛋白质合成抑制时确保mTOR的表达和功能。
RNA. 2017 Nov;23(11):1712-1728. doi: 10.1261/rna.063040.117. Epub 2017 Aug 18.
10
The molecular basis of mTORC1-regulated translation.mTORC1调节翻译的分子基础。
Biochem Soc Trans. 2017 Feb 8;45(1):213-221. doi: 10.1042/BST20160072.

引用本文的文献

1
Metabolic consequences of altered kidney glucose reabsorption under normoglycemic conditions.正常血糖条件下肾脏葡萄糖重吸收改变的代谢后果。
Mol Metab. 2025 Aug;98:102192. doi: 10.1016/j.molmet.2025.102192. Epub 2025 Jun 21.
2
Agr2 in cancer and beyond: unraveling its role during protein synthesis, ER stress, and as a predictive biomarker.Agr2在癌症及其他领域:揭示其在蛋白质合成、内质网应激过程中的作用以及作为预测性生物标志物的作用
Mol Cell Biochem. 2025 Jun 5. doi: 10.1007/s11010-025-05318-8.
3
eIF4F-mediated dysregulation of mRNA translation in cancer.真核生物起始因子4F(eIF4F)介导的癌症中mRNA翻译失调
RNA. 2025 Feb 19;31(3):416-428. doi: 10.1261/rna.080340.124.
4
Stress-Induced Eukaryotic Translational Regulatory Mechanisms.应激诱导的真核生物翻译调控机制
J Clin Med Sci. 2024;8(2). Epub 2024 Jun 24.
5
Blocking tumor-intrinsic MNK1 kinase restricts metabolic adaptation and diminishes liver metastasis.阻断肿瘤内在 MNK1 激酶可限制代谢适应并减少肝转移。
Sci Adv. 2024 Sep 13;10(37):eadi7673. doi: 10.1126/sciadv.adi7673.
6
Investigation of Common Pathways and Putative Biomarker Candidates of Colorectal Cancer and Insomnia by Using Integrative Approaches.运用整合方法对结直肠癌与失眠的共同通路及潜在生物标志物候选物进行研究。
Iran J Biotechnol. 2024 Apr 1;22(2):e3827. doi: 10.30498/ijb.2024.422185.3827. eCollection 2024 Apr.
7
Stress-induced Eukaryotic Translational Regulatory Mechanisms.应激诱导的真核生物翻译调控机制
ArXiv. 2024 May 2:arXiv:2405.01664v1.
8
JUN mRNA translation regulation is mediated by multiple 5' UTR and start codon features.JUN mRNA 的翻译调控是由多个 5'UTR 和起始密码子特征介导的。
PLoS One. 2024 Mar 14;19(3):e0299779. doi: 10.1371/journal.pone.0299779. eCollection 2024.
9
mRNA Translation Regulation is Mediated by Multiple 5' UTR and Start Codon Features.mRNA翻译调控由多个5'非翻译区和起始密码子特征介导。
bioRxiv. 2023 Nov 17:2023.11.17.567602. doi: 10.1101/2023.11.17.567602.
10
Ribonucleic Acid-Mediated Control of Protein Translation Under Stress.应激状态下 RNA 介导的蛋白质翻译调控
Antioxid Redox Signal. 2023 Aug;39(4-6):374-389. doi: 10.1089/ars.2023.0233.

本文引用的文献

1
mTOR Controls Mitochondrial Dynamics and Cell Survival via MTFP1.mTOR 通过 MTFP1 控制线粒体动态和细胞存活。
Mol Cell. 2017 Sep 21;67(6):922-935.e5. doi: 10.1016/j.molcel.2017.08.013. Epub 2017 Sep 14.
2
The Dawn of the Age of Amino Acid Sensors for the mTORC1 Pathway.mTORC1信号通路氨基酸传感器时代的曙光
Cell Metab. 2017 Aug 1;26(2):301-309. doi: 10.1016/j.cmet.2017.07.001.
3
Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer.核 mTOR 作为雄激素信号通路在前列腺癌中的转录整合因子。
Genes Dev. 2017 Jun 15;31(12):1228-1242. doi: 10.1101/gad.299958.117. Epub 2017 Jul 19.
4
Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK.果糖-1,6-二磷酸和醛缩酶通过AMPK介导葡萄糖感知。
Nature. 2017 Aug 3;548(7665):112-116. doi: 10.1038/nature23275. Epub 2017 Jul 19.
5
Efficient and Accurate Translation Initiation Directed by TISU Involves RPS3 and RPS10e Binding and Differential Eukaryotic Initiation Factor 1A Regulation.由TISU指导的高效准确的翻译起始涉及RPS3和RPS10e结合以及真核起始因子1A的差异调控。
Mol Cell Biol. 2017 Jul 14;37(15). doi: 10.1128/MCB.00150-17. Print 2017 Aug 1.
6
p62/SQSTM1 Cooperates with Hyperactive mTORC1 to Regulate Glutathione Production, Maintain Mitochondrial Integrity, and Promote Tumorigenesis.p62/SQSTM1与过度活跃的mTORC1协同作用,调节谷胱甘肽生成、维持线粒体完整性并促进肿瘤发生。
Cancer Res. 2017 Jun 15;77(12):3255-3267. doi: 10.1158/0008-5472.CAN-16-2458. Epub 2017 May 16.
7
mTORC1 Balances Cellular Amino Acid Supply with Demand for Protein Synthesis through Post-transcriptional Control of ATF4.mTORC1通过对ATF4的转录后调控平衡细胞氨基酸供应与蛋白质合成需求。
Cell Rep. 2017 May 9;19(6):1083-1090. doi: 10.1016/j.celrep.2017.04.042.
8
mTORC1 signaling and the metabolic control of cell growth.mTORC1信号传导与细胞生长的代谢调控
Curr Opin Cell Biol. 2017 Apr;45:72-82. doi: 10.1016/j.ceb.2017.02.012. Epub 2017 Apr 12.
9
mTOR Signaling in Growth, Metabolism, and Disease.生长、代谢及疾病中的mTOR信号传导
Cell. 2017 Mar 9;168(6):960-976. doi: 10.1016/j.cell.2017.02.004.
10
Resistance to mTORC1 Inhibitors in Cancer Therapy: From Kinase Mutations to Intratumoral Heterogeneity of Kinase Activity.癌症治疗中对mTORC1抑制剂的耐药性:从激酶突变到激酶活性的肿瘤内异质性
Oxid Med Cell Longev. 2017;2017:1726078. doi: 10.1155/2017/1726078. Epub 2017 Feb 9.